tezosentan has been researched along with Coronary Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, KF; Frey, A; Gattis, WA; Gheorghiade, M; Kobrin, I; O'Connor, CM; Shah, MR | 1 |
| Adams, KF; Chandler, B; Frey, A; Gattis, WA; Gheorghiade, M; Hasselblad, V; Kobrin, I; O'Connor, CM; Rainisio, M; Shah, MR; Teerlink, J | 1 |
| Adams, KF; Gattis, WA; Gheorghiade, M; Hasselblad, V; Kobrin, I; O'Connor, CM | 1 |
3 trial(s) available for tezosentan and Coronary Disease
| Article | Year |
|---|---|
Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the Randomized Intravenous Tezosentan study (RITZ-4).
Topics: Acute Disease; Adult; Child; Coronary Disease; Double-Blind Method; Endothelins; Female; Heart Failure; Humans; Myocardial Infarction; Pyridines; Recurrence; Syndrome; Tetrazoles; Vasodilator Agents | 2002 |
Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4).
Topics: Acute Disease; Aged; Coronary Disease; Double-Blind Method; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Outcome Assessment, Health Care; Pilot Projects; Pyridines; Syndrome; Tetrazoles; Vasodilator Agents | 2003 |
Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial).
Topics: Acute Disease; Aged; Coronary Disease; Endothelin Receptor Antagonists; Female; Heart Failure; Humans; Male; Multicenter Studies as Topic; Pyridines; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Tetrazoles; Troponin I; Vasodilator Agents | 2004 |